Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May-Jun;7(5-6):E417-20.
doi: 10.5489/cuaj.1395.

Simultaneous bilateral subcutaneous pyelovesical bypass as a salvage procedure in refractory retroperitoneal fibrosis

Affiliations

Simultaneous bilateral subcutaneous pyelovesical bypass as a salvage procedure in refractory retroperitoneal fibrosis

Nicholas Haddad et al. Can Urol Assoc J. 2013 May-Jun.

Abstract

Ureteral obstruction causing renal failure is the most common complication associated with retroperitoneal fibrosis (RPF). Initial management includes steroid therapy together with ureteral stenting. When these fail, ureterolysis is the recommended surgical procedure. However, this could be challenging and recurrence is common. The aim of the present case series was to assess the feasibility of inserting simultaneous bilateral subcutaneous pyelovesical bypass grafts (SPBGs) in patients presenting with RPF who had failed initial endourologic/surgical management.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
A computed tomography scan taken at the 14-month follow-up revealed bilateral resolution of hydronephrosis in the presence of a persistent retroperitoneal mass encasing the aorta and inferior vena cava. The subcutaneous pyelovesical bypass grafts remain properly positioned as the radiopaque mark of the prosthesis can be found between the renal parenchyma and calyx bilaterally.
Fig. 2.
Fig. 2.
A 3D-reconstruction using computed tomography-derived images shows bilateral subcutaneous pyelovesical bypass graft implants.

Similar articles

Cited by

References

    1. Koep L, Zuidema GD. The clinical significance of retroperitoneal fibrosis. Surgery. 1977;81:250–7. - PubMed
    1. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006;367:241–51. doi: 10.1016/S0140-6736(06)68035-5. - DOI - PubMed
    1. van Bommel EF, Jansen I, Hendriksz TR, et al. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore) 2009;88:193–201. doi: 10.1097/MD.0b013e3181afc420. - DOI - PubMed
    1. Baker LR, Mallinson WJ, Gregory MC, et al. Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol. 1987;60:497–503. doi: 10.1111/j.1464-410X.1987.tb05028.x. - DOI - PubMed
    1. Vaglio A, Corradi D, Manenti L, et al. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med. 2003;114:454–62. doi: 10.1016/S0002-9343(03)00056-1. - DOI - PubMed

LinkOut - more resources